<?xml version="1.0" encoding="UTF-8"?>
<p>Many organizations operate within the end-to-end space of vaccine funding and R&amp;D implementation. However, several critical gaps have been identified, which CEPI is designed to fill (Fig.Â 
 <xref rid="Fig1" ref-type="fig">1</xref>). The R&amp;D is complex, lengthy and expensive; the potential market for such vaccines against EIDs is very limited; and testing of such vaccines is difficult [
 <xref ref-type="bibr" rid="CR17">17</xref>].
</p>
